Back To: Home : Resources : Calendar of Events : Today's Events



Events for November 7, 2017


National Cancer Research Institute Cancer Conference 2017
Location: Liverpool, UK
The BT Convention Centre
Kings Dock,
Liverpool ENGLAND
November 5 - 8, 2017

4th Human Abuse Liability and Abuse Deterrent Formulations Summit,
Location: Washington, DC
Attend the largest and most specifically focused educational event devoted to improving trial designs, engineering less abuse-prone molecules and delivery systems, and tracking the performance and market uptake of opioids in order to document the success of abuse-deterrent methods.  

High-Content Analysis & 3 D Screening
Location: Cambridge, Ma
High-Content Analysis & 3 D Screening
November 6 - 8, 2017 | Cambridge, Ma

Cambridge Healthtech Institute’s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program and two dedicated tracks. The High-Content Analysis track will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Phenotypic Screening track will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma.

Featured Speakers Include:
  • Paul Andrews, Director, National Phenotypic Screening Centre, University of Dundee
  • Anthony M. Davies, Director, Translational Cell Imaging, Queensland University of Technology
  • Erik Hett, Team Leader, Chemical & Molecular Therapeutics, Biogen
  • Susanne Heynen-Genel, Director, High-Content Screening, Sanford Burnham Prebys Medical Discovery Institute
  • Zhuyin Li, Team Lead, Lead Discovery & Optimization, Bristol-Myers Squibb
  • Ulrich Schopfer, Head, Integrated Lead Discovery, Novartis
  • D. Lansing Taylor, Director, University of Pittsburgh Drug Discovery Institute
  • Alan Waggoner, Director, Molecular Biosensor and Imaging Center, Carnegie Mellon University
  • Wei Zheng, Group Leader, Preclinical Innovation, NCATS
Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and interactive dinner courses.

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.